Skip to main content
. 2019 Aug 5;2019:2345042. doi: 10.1155/2019/2345042

Table 2.

Baseline measurements for the placebo and RPC groups in the ITT population (n=144).

Variable Placebo (n = 72) RPC (n = 72) p-valuea
SBP (mmHg)
 Mean ± SD 147.3 ± 8.3 144.4 ± 6.5 0.019
 Median (Min – Max) 146.5  (116.7 – 182.3) 144.0  (125.0 – 160.0)
DBP (mmHg)
 Mean ± SD 88.1 ± 8.3 86.9 ± 6.7 0.329
 Median (Min – Max) 89.7  (57.3 – 109.3) 86.0  (71.0 – 100.3)
Heart Rate (BPM)
 Mean ± SD 71.3 ± 8.3 73.4 ± 8.7 0.139
 Median (Min – Max) 73.3  (53.0 – 87.3) 72.0  (57.7 – 97.7)
Height (cm)
 Mean ± SD 171.8 ± 9.7 171.0 ± 9.6 0.593
 Median (Min – Max) 170.5  (149.2 – 195.0) 170.5  (150.0 – 188.0)
Weight (kg)
 Mean ± SD 81.2 ± 13.4 81.2 ± 11.9 0.999
 Median (Min – Max) 79.7  (60.1 – 119.0) 81.1  (61.4 – 116.9)
BMI (kg/m 2)
 Mean ± SD 27.4 ± 3.1 27.8 ± 3.3 0.507
 Median (Min – Max) 26.8  (22.8 – 34.9) 27.4  (20.9 – 34.8)

BMI: body mass index; BPM: beats per minute; cm: centimeters; DBP: diastolic blood pressure; kg: kilograms; kg/m2: kilogram per square meter; Max: maximum; Min: minimum; mmHg: millimeter of mercury; n: number; RPC: Refined Peptide Concentrate; SBP: systolic blood pressure; SD: standard deviation

aBetween-group comparisons were made using the Independent Student t-test. p≤0.05 was considered statistically significant.